The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study - PubMed (original) (raw)

Comparative Study

The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study

David C Taylor-Robinson et al. Lancet Respir Med. 2013 Apr.

Abstract

Background: Poorer socioeconomic circumstances have been linked with worse outcomes in cystic fibrosis. We assessed whether a relation exists between social deprivation and individual's clinical and health-care outcomes.

Methods: We did a longitudinal registry study of the UK cystic fibrosis population younger than 40 years (8055 people with 49337 observations for weight, the most commonly collected outcome, between Jan 1, 1996, and Dec 31, 2009). We assessed data for weight, height, body-mass index, percent predicted forced expiratory volume in 1 s (%FEV1), risk of Pseudomonas aeruginosa colonisation, and the use of major cystic fibrosis treatment modalities. We used mixed effects models to assess the association between small-area deprivation and clinical and health-care outcomes, adjusting for clinically important covariates. We give continuous outcomes as mean differences, and binary outcomes as odds ratios, comparing extremes of deprivation quintile.

Findings: Compared with the least deprived areas, children from the most deprived areas weighed less (standard deviation [SD] score -0·28, 95% CI -0·38 to -0·18), were shorter (-0·31, -0·40 to -0·21, and had a lower body-mass index (-0·13, -0·22 to -0·04), were more likely to have chronic P aeruginosa infection (odds ratio 1·89, 95% CI 1·34 to 2·66), and have a lower %FEV1 (-4·12 percentage points, 95% CI -5·01 to -3·19). These inequalities were apparent very early in life and did not widen thereafter. On a population level, after adjustment for disease severity, children in the most deprived quintile were more likely to receive intravenous antibiotics (odds ratio 2·52, 95% CI 1·92 to 3·17) and nutritional treatments (1·78, 1·44 to 2·20) compared with individuals in the least deprived quintile. Patients from the most disadvantaged areas were less likely to receive DNase or inhaled antibiotic treatment.

Interpretation: In the UK, children with cystic fibrosis from more disadvantaged areas have worse growth and lung function compared with children from more affluent areas, but these inequalities do not widen with advancing age. Clinicians consider deprivation status, as well as disease status, when making decisions about treatments, and this might mitigate some effects of social disadvantage.

Funding: Medical Research Council (UK).

Copyright © 2013 Elsevier Ltd. All rights reserved.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Comparison of anthropometric outcomes, by age and socioeconomic status Mean cross-sectional (A) weight, (B) height, and (C) body-mass index (BMI).

Figure 2

Figure 2

Comparison of respiratory outcomes, by age and socioeconomic status Mean cross-sectional (A) FEV1 and (B) Pseudomonas aeruginosa colonisation prevalence.

Figure 3

Figure 3

Comparison of treatment methods, by age and socioeconomic status Proportion of patients who received (A) any intravenous antibiotic treatment, (B) home intravenous antibiotic treatment, (C) hospital intravenous antibiotic treatment, (D) supplemental feeding, (E) DNase, and (F) inhaled antibiotics.

Comment in

Similar articles

Cited by

References

    1. Cystic Fibrosis Trust UK CF Registry annual data report 2010. http://www.cftrust.org.uk/aboutcf/publications/cfregistryreports/ (accessed Sept 28, 2012).
    1. Schechter MS, Shelton BJ, Margolis PA, Fitzsimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med. 2001;163:1331–1337. - PubMed
    1. O'Connor GT, Quinton HB, Kneeland T. Median household income and mortality rate in cystic fibrosis. Pediatrics. 2003;111:e333–e339. - PubMed
    1. Britton JR. Effects of social class, sex, and region of residence on age at death from cystic fibrosis. BMJ. 1989;298:483–487. - PMC - PubMed
    1. Barr HLSA, Fogarty AW. The association between socioeconomic status and gender with median age at death from cystic fibrosis in England and Wales: 1959 to 2008. BMJ. 2011;343:d4662. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources